STEVEN DIAMOND: Open Payments
NPI 1245272293 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 108 payments from 16 companies in 2025. Trend: 2023 $2,343 · 2024 $2,102 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $284 |
| Janssen Pharmaceuticals, Inc | 10 | $273 |
| E.R. Squibb & Sons, L.L.C. | 10 | $252 |
| Lundbeck LLC | 15 | $206 |
| Alkermes, Inc. | 11 | $170 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Corium, LLC | 8 | $106 |
| Supernus Pharmaceuticals, Inc. | 5 | $99 |
| ABBVIE INC. | 5 | $99 |
Products named: REXULTI, TRINTELLIX, SPRAVATO, COBENFY, LYBALVI, Auvelity, Azstarys, Qelbree.
Industry payments across NY — which companies pay providers there.
